H1B Report
Side-by-side comparison

NOVARTIS PHARMACEUTICALS CORPORATION vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
NOVARTIS PHARMACEUTICALS CORPORATION
NJRank #FEIN 22-1857084
Entity B
WIPRO LIMITED
NJRank #5FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricNOVARTIS PHARMACEUTICALS CORPORATIONWIPRO LIMITED
Total filings88971,022▲
Certified %40.16%▲8.45%
Denied %0.00%0.00%
Withdrawn %0.45%0.15%
Cert-withdrawn %0.34%0.58%
Rank—#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJNJ

Outcomes — NOVARTIS PHARMACEUTICALS CORPORATION

DOL case-status mix.

Outcome breakdown: Certified 98.1%, Cert-withdrawn 0.8%, Withdrawn 1.1%
Outcome breakdown
OutcomeShare
Certified98.1%
Cert-withdrawn0.8%
Withdrawn1.1%
Certified98.1%
Cert-withdrawn0.8%
Withdrawn1.1%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 92.0%, Cert-withdrawn 6.3%, Withdrawn 1.6%
Outcome breakdown
OutcomeShare
Certified92.0%
Cert-withdrawn6.3%
Withdrawn1.6%
Certified92.0%
Cert-withdrawn6.3%
Withdrawn1.6%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

NOVARTIS PHARMACEUTICALS CORPORATION
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201052
FY201145
FY201259
FY201344
FY201461
FY201548
FY201663
FY201753
FY201840
FY201960
FY202028
FY202143
FY202219
FY202344
FY202491
FY2025114
FY202625
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,018
FY20113,025
FY20126,933
FY20136,525
FY20148,008
FY201511,733
FY201610,233
FY20174,938
FY20186,036
FY20194,053
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,062

Top 5 occupations — NOVARTIS PHARMACEUTICALS CORPORATION

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Swap A: NOVARTIS PHARMACEUTICALS CORPORATION
INFOSYS LIMITEDTATA CONSULTANCY SERVICES LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPDeloitte Consulting LLP
Swap B: WIPRO LIMITED
INFOSYS LIMITEDTATA CONSULTANCY SERVICES LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPDeloitte Consulting LLP
Or browse the full sponsor index.
NOVARTIS PHARMACEUTICALS CORPORATIONWIPRO LIMITEDBrowse all
NOVARTIS PHARMACEUTICALS CORPORATION vs WIPRO LIMITED — H-1B Sponsor Comparison · H1B Report